Menopause and hormone replacement therapy: effects on the immune system, arthritis and bone

por Carlsten, H, D'Elia, H Forsblad, Erlandsson, M, Islander, U
Publicado 2004

Hepatocyte growth factor is a potential biomarker for osteoproliferation and osteoporosis in ankylosing spondylitis

por Torres, L., Klingberg, E., Nurkkala, M., Carlsten, H., Forsblad-d’Elia, H.
Publicado 2018

Correction to: Factors associated with changes in volumetric bone mineral density and cortical area in men with ankylosing spondylitis: a 5-year prospective study using HRpQCT.

por Deminger, A., Klingberg, E., Lorentzon, M., Hedberg, M., Carlsten, H., Jacobsson, L. T. H., Forsbladd’Elia, H.
Publicado 2021

Factors associated with changes in volumetric bone mineral density and cortical area in men with ankylosing spondylitis: a 5-year prospective study using HRpQCT.

por Deminger, A., Klingberg, E., Lorentzon, M., Hedberg, M., Carlsten, H., Jacobsson, L.T.H., Forsblad-d’Elia, H.
Publicado 2021

Interleukin 17A: a Janus-faced regulator of osteoporosis

por Scheffler, J. M., Grahnemo, L., Engdahl, C., Drevinge, C., Gustafsson, K. L., Corciulo, C., Lawenius, L., Iwakura, Y., Sjögren, K., Lagerquist, M. K., Carlsten, H., Ohlsson, C., Islander, U.
Publicado 2020

ERα expression in T lymphocytes is dispensable for estrogenic effects in bone

por Gustafsson, K L, Nilsson, K H, Farman, H H, Andersson, A, Lionikaite, V, Henning, P, Wu, J, Windahl, S H, Islander, U, Movérare-Skrtic, S, Sjögren, K, Carlsten, H, Gustafsson, J-Å, Ohlsson, C, Lagerquist, M K
Publicado 2018